| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |